TY - JOUR
TI - Brentuximab vedotin for Hodgkin lymphoma and anaplastic large cell lymphoma
J2 - Aust Prescr
JF - Australian Prescriber
PY - 2014
ET - 2014/07/30
VL - 37
IS - 5
SP - 172
EP - 179
DO - 10.18773/austprescr.2014.070
LA - eng
UR - https://australianprescriber.tg.org.au/articles/brentuximab-vedotin-for-hodgkin-lymphoma-and-anaplastic-large-cell-lymphoma.html
KW - Adcetris
KW - brentuximab vedotin
KW - large cell anaplastic lymphoma
KW - Hodgkin lymphoma
KW - Hodgkin's disease
PB - Therapeutic Guidelines Ltd
SN - 1839-3942
ER -